메뉴 건너뛰기




Volumn 27, Issue 1, 2012, Pages 23-35

Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing

Author keywords

chemoimmunotherapy; cisplatin; lung; T cell response; vinorelbine

Indexed keywords

CANCER VACCINE; CISPLATIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANZYME; INTERLEUKIN 8; NAVELBINE; PERFORIN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

EID: 84856879058     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1203     Document Type: Article
Times cited : (36)

References (67)
  • 1
    • 0003964363 scopus 로고    scopus 로고
    • American Cancer Society Atlanta: American Cancer Society. 2008.
    • American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society. 2008.
    • (2008) Cancer Facts Figures
  • 2
    • 0003719393 scopus 로고    scopus 로고
    • Abraham J, Allegra CJ, Gulley JL, eds 2nd ed. Philadelphia: Lippincott Williams & Wilkins
    • Abraham J, Allegra CJ, Gulley JL, eds. Bethesda Handbook of Clinical Oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
    • (2005) Bethesda Handbook of Clinical Oncology
  • 5
    • 50349091770 scopus 로고    scopus 로고
    • Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: Effects of docetaxel on immune enhancement
    • Garnett CT, Schlom J, Hodge JW. Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: Effects of docetaxel on immune enhancement. Clin Cancer Res 2008;14:3536-3544.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 3536-3544
    • Garnett, C.T.1    Schlom, J.2    Hodge, J.W.3
  • 6
    • 70349416505 scopus 로고    scopus 로고
    • Vaccines for the treatment of non-small cell lung cancer: A renewed anticancer strategy
    • Gridelli C, Rossi A, Maione P, et al. Vaccines for the treatment of non-small cell lung cancer: A renewed anticancer strategy. Oncologist 2009;14:909-920.
    • (2009) Oncologist , vol.14 , pp. 909-920
    • Gridelli, C.1    Rossi, A.2    Maione, P.3
  • 7
    • 68549135290 scopus 로고    scopus 로고
    • Integrated data from 2 randomized double-blind placebo-controlled phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
    • Higano CS, Schellhammer PF, Small EJ, et al. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer 2009;115:3670-3679.
    • (2009) Cancer , vol.115 , pp. 3670-3679
    • Higano, C.S.1    Schellhammer, P.F.2    Small, E.J.3
  • 8
    • 80054701176 scopus 로고    scopus 로고
    • Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccinemediated antitumor responses
    • Gameiro SR, Caballero JA, Higgins JP, et al. Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccinemediated antitumor responses. Cancer Immunol Immunother 2011;60:1227-1242.
    • (2011) Cancer Immunol. Immunother , vol.60 , pp. 1227-1242
    • Gameiro, S.R.1    Caballero, J.A.2    Higgins, J.P.3
  • 9
    • 79951826832 scopus 로고    scopus 로고
    • Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: The growth rate constant as an indicator of therapeutic efficacy
    • Stein WD, Gulley JL, Schlom J, et al. Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: The growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res 2011;17:907-917.
    • (2011) Clin. Cancer Res. , vol.17 , pp. 907-917
    • Stein, W.D.1    Gulley, J.L.2    Schlom, J.3
  • 10
    • 33645669207 scopus 로고    scopus 로고
    • Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis
    • Gelbard A, Garnett CT, Abrams SI, et al. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Clin Cancer Res 2006;12:1897-1905.
    • (2006) Clin. Cancer Res. , vol.12 , pp. 1897-1905
    • Gelbard, A.1    Garnett, C.T.2    Abrams, S.I.3
  • 11
    • 0029042336 scopus 로고
    • Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
    • Tsang KY, Zaremba S, Nieroda CA, et al. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 1995; 87:982-990.
    • (1995) J. Natl. Cancer Inst. , vol.87 , pp. 982-990
    • Tsang, K.Y.1    Zaremba, S.2    Nieroda, C.A.3
  • 12
    • 7444258053 scopus 로고    scopus 로고
    • Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes
    • DOI 10.1158/0008-5472.CAN-04-1525
    • Garnett CT, Palena C, Chakraborty M, et al. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 2004;64:7985-7994. (Pubitemid 39446933)
    • (2004) Cancer Research , vol.64 , Issue.21 , pp. 7985-7994
    • Garnett, C.T.1    Palena, C.2    Chakarborty, M.3    Tsang, K.-Y.4    Schlom, J.5    Hodge, J.W.6
  • 14
    • 34247117387 scopus 로고    scopus 로고
    • Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokineactivated killer cells
    • Law KS, Chen HC, Liao SK. Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokineactivated killer cells. Anticancer Res 2007;27:841-850.
    • (2007) Anticancer Res. , vol.27 , pp. 841-850
    • Law, K.S.1    Chen, H.C.2    Liao, S.K.3
  • 15
    • 38949174590 scopus 로고    scopus 로고
    • Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-κB dependent pathway
    • DOI 10.1111/j.1349-7006.2008.00696.x
    • Yu M, Han J, Cui P, et al. Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-kappaB dependent pathway. Cancer Sci 2008;99:391-397. (Pubitemid 351228497)
    • (2008) Cancer Science , vol.99 , Issue.2 , pp. 391-397
    • Yu, M.1    Han, J.2    Cui, P.3    Dai, M.4    Li, H.5    Zhang, J.6    Xiu, R.7
  • 16
    • 33846997837 scopus 로고    scopus 로고
    • Effects of cisplatin alpha-interferon and 13-cis retinoic acid on the expression of Fas CD95 intercellular adhesion molecule-1 ICAM-1 and epidermal growth factor receptor EGFR in oral cancer cell lines
    • Sundelin K, Roberg K, Grenman R, Hakansson L. Effects of cisplatin, alpha-interferon, and 13-cis retinoic acid on the expression of Fas (CD95), intercellular adhesion molecule-1 (ICAM-1), and epidermal growth factor receptor (EGFR) in oral cancer cell lines. J Oral Pathol Med 2007;36:177-183.
    • (2007) J. Oral. Pathol. Med. , vol.36 , pp. 177-183
    • Sundelin, K.1    Roberg, K.2    Grenman, R.3    Hakansson, L.4
  • 17
    • 0028486130 scopus 로고
    • Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes
    • Kojima H, Shinohara N, Hanaoka S, et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994;1:357-364.
    • (1994) Immunity , vol.1 , pp. 357-364
    • Kojima, H.1    Shinohara, N.2    Hanaoka, S.3
  • 18
    • 0037570795 scopus 로고    scopus 로고
    • Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy
    • DOI 10.1159/000070658
    • Modrak DE, Gold DV, Goldenberg DM, Blumenthal RD. Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy. Tumour Biol 2003; 24:32-39. (Pubitemid 36578816)
    • (2003) Tumor Biology , vol.24 , Issue.1 , pp. 32-39
    • Modrak, D.E.1    Gold, D.V.2    Goldenberg, D.M.3    Blumenthal, R.D.4
  • 19
    • 52949085860 scopus 로고    scopus 로고
    • Combined effects of 5-fluorouracil folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: Pharmacological basis to develop an active antitumor immunochemotherapy
    • Prete SP, Turriziani M, Massara MC, et al. Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: Pharmacological basis to develop an active antitumor immunochemotherapy. J Exp Clin Cancer Res 2008;27:5.
    • (2008) J. Exp. Clin. Cancer Res. , vol.27 , pp. 5
    • Prete, S.P.1    Turriziani, M.2    Massara, M.C.3
  • 20
    • 0038069515 scopus 로고    scopus 로고
    • MHC class i antigens, immune surveillance, and tumor immune escape
    • DOI 10.1002/jcp.10290
    • Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 2003;195:346-355. (Pubitemid 36529863)
    • (2003) Journal of Cellular Physiology , vol.195 , Issue.3 , pp. 346-355
    • Garcia-Lora, A.1    Algarra, I.2    Garrido, F.3
  • 21
    • 0033973608 scopus 로고    scopus 로고
    • Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine
    • Zhu MZ, Marshall J, Cole D, et al. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine. Clin Cancer Re 2000;6: 24-33. (Pubitemid 30064972)
    • (2000) Clinical Cancer Research , vol.6 , Issue.1 , pp. 24-33
    • Zhu, M.1    Marshall, J.2    Cole, D.3    Schlom, J.4    Tsang, K.Y.5
  • 23
    • 0030005837 scopus 로고    scopus 로고
    • Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity
    • Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996;156:3678-3686. (Pubitemid 26139940)
    • (1996) Journal of Immunology , vol.156 , Issue.10 , pp. 3678-3686
    • Kataoka, T.1    Shinohara, N.2    Takayama, H.3    Takaku, K.4    Kondo, S.5    Yonehara, S.6    Nagai, K.7
  • 24
    • 0038819943 scopus 로고    scopus 로고
    • Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-κB through the Akt pathway
    • DOI 10.1074/jbc.M211695200
    • Mayo MW, Denlinger CE, Broad RM, et al. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem 2003;278:18980-18989. (Pubitemid 36799282)
    • (2003) Journal of Biological Chemistry , vol.278 , Issue.21 , pp. 18980-18989
    • Mayo, M.W.1    Denlinger, C.E.2    Broad, R.M.3    Yeung, F.4    Reilly, E.T.5    Shi, Y.6    Jones, D.R.7
  • 25
    • 80053326169 scopus 로고    scopus 로고
    • Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
    • Wang Y, Qu Y, Niu XL, et al. Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cytokine 2011;56:365-375.
    • (2011) Cytokine , vol.56 , pp. 365-375
    • Wang, Y.1    Qu, Y.2    Niu, X.L.3
  • 26
    • 77549083441 scopus 로고    scopus 로고
    • Transforming growth factor beta TGFbeta and inflammation in cancer
    • Bierie B, Moses HL. Transforming growth factor beta (TGFbeta) and inflammation in cancer. Cytokine Growth Factor Rev 2010;21:49-59.
    • (2010) Cytokine Growth Factor Rev. , vol.21 , pp. 49-59
    • Bierie, B.1    Moses, H.L.2
  • 27
    • 72549116879 scopus 로고    scopus 로고
    • Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma
    • Yanagawa J, Walser TC, Zhu LX, et al. Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res 2009;15:6820-6829.
    • (2009) Clin. Cancer Res. , vol.15 , pp. 6820-6829
    • Yanagawa, J.1    Walser, T.C.2    Zhu, L.X.3
  • 29
    • 79955753093 scopus 로고    scopus 로고
    • Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis
    • Chen C, Fu X, Zhang D, et al. Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis. Int J Biol Sci 2011;7:551-566.
    • (2011) Int. J. Biol. Sci. , vol.7 , pp. 551-566
    • Chen, C.1    Fu, X.2    Zhang, D.3
  • 31
    • 65749116421 scopus 로고    scopus 로고
    • The effect of vinca alkaloid anticancer drug vinorelbine on chromatin and histone proteins in solution
    • Rabbani-Chadegani A, Chamani E, Hajihassan Z. The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution. Eur J Pharmacol 2009;613: 34-38.
    • (2009) Eur.J.Pharmacol. , vol.613 , pp. 34-38
    • Rabbani-Chadegani, A.1    Chamani, E.2    Hajihassan, Z.3
  • 34
    • 69749112731 scopus 로고    scopus 로고
    • PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis
    • Chipuk JE, Green DR. PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis. Cell Cycle 2009;8:2692-2696.
    • (2009) Cell Cycle , vol.8 , pp. 2692-2696
    • Chipuk, J.E.1    Green, D.R.2
  • 36
    • 84856862817 scopus 로고    scopus 로고
    • NOX5: From basic biology to signaling and disease
    • Epub ahead of print.
    • Bedard K, Jaquet V, Krause KH. NOX5: From basic biology to signaling and disease. Free Radic Biol Med 2011. Epub ahead of print.
    • (2011) Free Radic. Biol. Med.
    • Bedard, K.1    Jaquet, V.2    Krause, K.H.3
  • 37
    • 78650591943 scopus 로고    scopus 로고
    • BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells
    • Xu JD, Cao XX, Long ZW, et al. BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells. J Pathol 2011;223:400-409.
    • (2011) J. Pathol. , vol.223 , pp. 400-409
    • Xu, J.D.1    Cao, X.X.2    Long, Z.W.3
  • 38
    • 80051525374 scopus 로고    scopus 로고
    • Interleukin 1alpha sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancerassociated fibroblasts
    • Tjomsland V, Spangeus A, Vä lilä J, et al. Interleukin 1alpha sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancerassociated fibroblasts. Neoplasia 2011;13:664-675.
    • (2011) Neoplasia , vol.13 , pp. 664-675
    • Tjomsland, V.1    Spangeus, A.2    Välilä, J.3
  • 39
    • 66349109431 scopus 로고    scopus 로고
    • Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB
    • Melisi D, Niu J, Chang Z, et al. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB. Molec Cancer Res 2009;7:624-633.
    • (2009) Molec. Cancer Res. , vol.7 , pp. 624-633
    • Melisi, D.1    Niu, J.2    Chang, Z.3
  • 40
    • 79960920666 scopus 로고    scopus 로고
    • Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
    • Kaneno R, Shurin GV, Kaneno FM, et al. Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells. Cell Oncol (Dordr) 2011;34:97-106.
    • (2011) Cell Oncol. Dordr. , vol.34 , pp. 97-106
    • Kaneno, R.1    Shurin, G.V.2    Kaneno, F.M.3
  • 41
    • 77951178310 scopus 로고    scopus 로고
    • Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
    • Ramakrishnan R, Assudani D, Nagaraj S, et al. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. J Clin Invest 2010;120:1111-1124.
    • (2010) J. Clin. Invest. , vol.120 , pp. 1111-1124
    • Ramakrishnan, R.1    Assudani, D.2    Nagaraj, S.3
  • 42
    • 79952390627 scopus 로고    scopus 로고
    • Immune parameters affecting the efficacy of chemotherapeutic regimens
    • Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol 2011;8:151-160.
    • (2011) Nat. Rev. Clin. Oncol. , vol.8 , pp. 151-160
    • Zitvogel, L.1    Kepp, O.2    Kroemer, G.3
  • 43
    • 68349123372 scopus 로고    scopus 로고
    • Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism
    • Shurin GV, Tourkova IL, Kaneno R, Shurin MR. Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism. J Immunol 2009;183:137-144.
    • (2009) J. Immunol. , vol.183 , pp. 137-144
    • Shurin, G.V.1    Tourkova, I.L.2    Kaneno, R.3    Shurin, M.R.4
  • 45
    • 0028678979 scopus 로고
    • Lymphocyte binding to K562 cells: Effect of target cell irradiation and correlation with ICAM-1 and LFA-3 expression
    • Zamai L, Rana R, Mazzotti G, et al. Lymphocyte binding to K562 cells: Effect of target cell irradiation and correlation with ICAM-1 and LFA-3 expression. Eur J Histochem 1994; 38 (suppl 1):53-60.
    • (1994) Eur. J. Histochem. , vol.38 , Issue.1 , pp. 53-60
    • Zamai, L.1    Rana, R.2    Mazzotti, G.3
  • 46
    • 0032843881 scopus 로고    scopus 로고
    • How tumors escape immune destruction and what we can do about it
    • DOI 10.1007/s002620050590
    • Gilboa E. How tumors escape immune destruction and what we can do about it. Cancer Immunol Immunother 1999; 48:382-385. (Pubitemid 29461391)
    • (1999) Cancer Immunology Immunotherapy , vol.48 , Issue.7 , pp. 382-385
    • Gilboa, E.1
  • 47
    • 0345801302 scopus 로고    scopus 로고
    • Tumour MHC class i downregulation and immunotherapy Review
    • Bubenik J. Tumour MHC class I downregulation and immunotherapy (Review). Oncol Rep 2003;10:2005-2008.
    • (2003) Oncol. Rep. , vol.10 , pp. 2005-2008
    • Bubenik, J.1
  • 49
    • 0032945057 scopus 로고    scopus 로고
    • Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-κB independent pathway
    • DOI 10.1038/sj.bjc.6690449
    • Takizawa K, Kamijo R, Ito D, et al. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway. Br J Cancer 1999;80:954-963. (Pubitemid 29233915)
    • (1999) British Journal of Cancer , vol.80 , Issue.7 , pp. 954-963
    • Takizawa, K.1    Kamijo, R.2    Ito, D.3    Hatori, M.4    Sumitani, K.5    Nagumo, M.6
  • 51
    • 76649138588 scopus 로고    scopus 로고
    • The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
    • Fernando RI, Litzinger M, Trono P, et al. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest 2010;120: 533-544.
    • (2010) J. Clin. Invest. , vol.120 , pp. 533-544
    • Fernando, R.I.1    Litzinger, M.2    Trono, P.3
  • 52
    • 84873075505 scopus 로고    scopus 로고
    • Oncogenic KRASinduced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer
    • Epub ahead of print
    • Sunaga N, Imai H, Shimizu K, et al. Oncogenic KRASinduced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. Int J Cancer 2011. Epub ahead of print.
    • (2011) Int. J. Cancer
    • Sunaga, N.1    Imai, H.2    Shimizu, K.3
  • 53
    • 77956178360 scopus 로고    scopus 로고
    • EMT cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer
    • Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010;29:4741-4751.
    • (2010) Oncogene , vol.29 , pp. 4741-4751
    • Singh, A.1    Settleman, J.2
  • 54
    • 0036716281 scopus 로고    scopus 로고
    • The BCL2 family: Regulators of the cellular life-or-death switch
    • DOI 10.1038/nrc883
    • Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2002;2:647-656. (Pubitemid 37328916)
    • (2002) Nature Reviews Cancer , vol.2 , Issue.9 , pp. 647-656
    • Cory, S.1    Adams, J.M.2
  • 55
    • 17144427727 scopus 로고    scopus 로고
    • Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo
    • DOI 10.1038/sj.cdd.4401563
    • Huber C, Bobek N, Kuball J, et al. Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo. Cell Death Differ 2005;12:317-325. (Pubitemid 40520683)
    • (2005) Cell Death and Differentiation , vol.12 , Issue.4 , pp. 317-325
    • Huber, C.1    Bobek, N.2    Kuball, J.3    Thaler, S.4    Hoffarth, S.5    Huber, C.6    Theobald, M.7    Schuler, M.8
  • 56
    • 68949202516 scopus 로고    scopus 로고
    • Role of the unfolded protein response regulator GRP78/BiP in development cancer and neurological disorders
    • Wang M, Wey S, Zhang Y, et al. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal 2009;11:2307-2316.
    • (2009) Antioxid Redox. Signal , vol.11 , pp. 2307-2316
    • Wang, M.1    Wey, S.2    Zhang, Y.3
  • 57
    • 84873069349 scopus 로고    scopus 로고
    • PUMA chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x L and Mcl-1
    • Epub ahead of print.
    • Yuan Z, Cao K, Lin C, et al. PUMA chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1. Mol Med 2011. Epub ahead of print.
    • (2011) Mol. Med.
    • Yuan, Z.1    Cao, K.2    Lin, C.3
  • 58
  • 59
    • 36349029749 scopus 로고    scopus 로고
    • The role of tissue factor pathway inhibitor-2 in cancer biology
    • DOI 10.1055/s-2007-991532
    • Sierko E, Wojtukiewicz MZ, Kisiel W. The role of tissue factor pathway inhibitor-2 in cancer biology. Semin Thromb Hemost 2007;33:653-659. (Pubitemid 350157008)
    • (2007) Seminars in Thrombosis and Hemostasis , vol.33 , Issue.7 , pp. 653-659
    • Sierko, E.1    Wojtukiewicz, M.Z.2    Kisiel, W.3
  • 60
    • 78049518977 scopus 로고    scopus 로고
    • TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
    • Wang S, Xiao X, Zhou X, et al. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010;10:617.
    • (2010) BMC Cancer , vol.10 , pp. 617
    • Wang, S.1    Xiao, X.2    Zhou, X.3
  • 61
    • 79251610744 scopus 로고    scopus 로고
    • RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA
    • Zhang K, Chen D, Wang X, et al. RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA. Int J Mol Sci 2011;12: 385-400.
    • (2011) Int. J. Mol. Sci. , vol.12 , pp. 385-400
    • Zhang, K.1    Chen, D.2    Wang, X.3
  • 62
    • 80053353709 scopus 로고    scopus 로고
    • Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy
    • Hannani D, Sistigu A, Kepp O, et al. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer J 2011;17:351-358.
    • (2011) Cancer J. , vol.17 , pp. 351-358
    • Hannani, D.1    Sistigu, A.2    Kepp, O.3
  • 63
    • 78049523304 scopus 로고    scopus 로고
    • Desirable cell death during anticancer chemotherapy
    • Locher C, Conforti R, Aymeric L, et al. Desirable cell death during anticancer chemotherapy. Ann N Y Acad Sci 2010;1209:99-108.
    • (2010) Ann. N. Y. Acad. Sci. , vol.1209 , pp. 99-108
    • Locher, C.1    Conforti, R.2    Aymeric, L.3
  • 65
    • 0023812898 scopus 로고
    • Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol- specific phospholipase C
    • Sack TL, Gum JR, Low MG, Kim YS. Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol- specific phospholipase C. J Clin Invest. 1988;82:586-593.
    • (1988) J. Clin. Invest. , vol.82 , pp. 586-593
    • Sack, T.L.1    Gum, J.R.2    Low, M.G.3    Kim, Y.S.4
  • 67
    • 79956318603 scopus 로고    scopus 로고
    • TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT
    • Lalaoui N, Morle A, Merino D, et al. TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT. PloS one. 2011;6:e19679.
    • (2011) PloS One. , vol.6
    • Lalaoui, N.1    Morle, A.2    Merino, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.